StockData
UNITED THERAPEUTICS Corp logo

UNITED THERAPEUTICS Corp (UTHR) stock

UTHRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 11/3022% above fair value
$577.34−6.76 (-1.16%)

Close on Nov 18, 2026Market cap $24.76BP/E 20.7Yield –

Earnings

United Therapeutics's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Feb 24, 2027
Q4 FY2026 · estimated, before the open
Revenue, Q3 FY2026
$832.50M
+4.1% on a year earlier
Adjusted EPS, Q3 FY2026
$5.71
$7.16 a year earlier
Latest guidance
None
No outlook given in releases

Quarterly results

Revenue and earnings per share from each of United Therapeutics's earnings releases, newest first

QuarterReportedRevenueYoYEPSAdj. EPSSource
Q4 FY2026ended Dec 31, 2026Feb 24, 2027Expected–––––
Q3 FY2026ended Sep 30, 2026Nov 4, 2026before the open$832.50M+4.1%$5.71–Release
Q2 FY2026ended Jun 30, 2026Aug 5, 2026before the open$783.30M-1.9%$7.27–Release
Q1 FY2026ended Mar 31, 2026May 6, 2026before the open$781.50M-1.6%$5.82–Release
Q4 FY2025ended Dec 31, 2025Feb 25, 2026before the open$790.20M+7.4%$7.70–Release
Q3 FY2025ended Sep 30, 2025Oct 29, 2025before the open$799.50M+6.8%$7.16–Release
Q2 FY2025ended Jun 30, 2025Jul 30, 2025before the open$798.60M+11.7%$6.41–Release
Q1 FY2025ended Mar 31, 2025Apr 30, 2025before the open$794.40M+17.2%$6.63–Release
Q4 FY2024ended Dec 31, 2024Feb 26, 2025before the open$735.90M+19.7%$6.19–Release
Q3 FY2024ended Sep 30, 2024Oct 30, 2024before the open$748.90M+22.9%$6.39–Release
Q2 FY2024ended Jun 30, 2024Jul 31, 2024before the open$714.90M+19.8%$5.85–Release
Q1 FY2024ended Mar 31, 2024May 1, 2024before the open$677.70M+33.7%$6.17–Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Guidance

United Therapeutics has not given guidance in its releases

Many companies give their outlook only on the conference call or not at all. When United Therapeutics puts a forecast in an earnings release, it is listed here with the exact sentence.

Press releases

Releases United Therapeutics filed with the SEC as exhibits to Form 8-K or 6-K

  1. Results
  2. News
  3. News
  4. Update
  5. Results
  6. Update
  7. Results
  8. News
  9. Update
  10. Update
  11. Update
  12. Results
  13. Update
  14. Results
  15. News

See a number that looks wrong?